Spectranetics Acquires AngioScore for $230,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    5055 Brandin Court Fremont, CA 94538 USA
  • Company Description
    AngioScore, Inc. develops, makes and sells leading edge tools for endovascular therapy. Our first product, the AngioSculpt Scoring Balloon Catheter, has received CE mark approval and is available for sale in Europe. Clinical trials are underway in the United States.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The Spectranetics Corporation SPNC -8.25% today announced that it has entered into a definitive merger agreement under which Spectranetics will acquire AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons for $230 million in up-front consideration, along with additional contingent commercial and regulatory milestone payments.

Trending on Xconomy